Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Jiangsu Yuanda Xinyi Pharmaceutical is a China-based pharmaceutical manufacturer focused on steroid active pharmaceutical ingredients and related chemical intermediates. The company appears to operate primarily as a commercial-stage API supplier rather than a drug developer, with manufacturing centered in the Yancheng coastal chemical park in Jiangsu province. Public business descriptions indicate production of progesterone, medroxyprogesterone, exemestane, estradiol-series products, and other steroid compounds used in hormonal and specialty pharmaceutical markets. The company has GMP-compliant facilities and export capabilities, and it is majority owned by China Grand Group through the Yuanda/Grand corporate system. Based on available evidence, the requested name "Jiangsu Yuanda SYM Pharmaceutical" most likely refers to this company, with "SYM" being a mistaken or alternate romanization for Xinyi/信谊 rather than a separate biotech entity.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Jiangsu Yuanda Xinyi Pharmaceutical.